STAA - スタ―サ―ジカル （STAAR Surgical Company）

A share of STAAR Surgical Company (NASDAQ:STAA) closed at $72.96 per share on Wednesday, up from $70.55 day before. While STAAR Surgical Company has overperformed by 3.42%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, STAA rose by 0.33%, with highs and lows ranging from $112.27 […]

Shares of implantable lens manufacturer STAAR Surgical had fallen over 55% since August but are rebounding. Click here for our analysis of STAA stock.

https://www.investing.com/news/pro/staar-surgical-pt-raised-to-80-at-canaccord-genuity-432SI-2991093

During the recent session, STAAR Surgical Company (NASDAQ:STAA)’s traded shares were 0.48 million, with the beta value of the company hitting 1.08. At the last check today, the stock’s price was $65.96, reflecting an intraday loss of -6.72% or -$4.75. The 52-week high for the STAA share is $112.27, that puts it down -70.21 from … STAAR Surgical Company (NASDAQ: STAA) Stock: Boom Or Bust? What Happens Next? Read More »

STAAR Surgical Company (NASDAQ:STAA)’s traded shares stood at 0.73 million during the last session, with the company’s beta value hitting 1.05. At the close of trading, the stock’s price was $72.50, to imply an increase of 3.13% or $2.2 in intraday trading. The STAA share’s 52-week high remains $112.27, putting it -54.86% down since that … STAAR Surgical Company (NASDAQ: STAA) Surged -5.40% In 6 Months – Here’s What Happens Next Read More »

STAAR Surgical (STAA) presents with the fundamental momentum that we feel can drive equity returns into the coming years. See why we rate STAA stock a buy.

STAAR Surgical Company (NASDAQ:STAA) shares, rose in value on Friday, 06/24/22, with the stock price up by 3.72% to the previous day’s close as strong demand from buyers drove the stock to $74.78. Actively observing the price movement in the last trading, the stock closed the session at $72.10, falling within a range of $71.00 … STAAR Surgical Company (NASDAQ: STAA) Stock Price Forecast: $100 Read More »

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that more than two million Visian Implantable Collamer lenses (“ICLs”) have been sold globally, including more than one and a half million of the company’s latest generation of implantable lenses – EVO Visian ICLs (“EVO”).

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that more than two million Visian® Implantable Collamer lenses (“ICLs”) have been sold globally, including more than one and a half million of the company’s latest generation of implantable lenses – EVO Visian® ICLs (“EVO”). New to the U.S. market, EVO is available in more than 75 countries a

STAAR Surgical Company (NASDAQ:STAA)’s traded shares stood at 0.35 million during the last session, with the company’s beta value hitting 1.13. At the close of trading, the stock’s price was $67.04, to imply an increase of 6.65% or $4.18 in intraday trading. The STAA share’s 52-week high remains $163.08, putting it -143.26% down since that … STAAR Surgical Company (NASDAQ: STAA) Stock Gained 12.14% Over A Month – Any Room To Run? Read More »

Another factual information on the "Intraocular Lens Market" has as of late added by CMI to its storehouse. This global research report offers an inside and out examination of various perspectives, for example, global market patterns, pieces of the overall

Stephens Inc. AR trimmed its holdings in shares of STAAR Surgical (NASDAQ:STAA) by 23.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,636 shares of the medical instruments suppliers stock after selling 1,712 shares during the period. Stephens Inc. ARs holdings in []

Strs Ohio trimmed its stake in STAAR Surgical (NASDAQ:STAA) by 21.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 12,200 shares of the medical instruments suppliers stock after selling 3,400 shares during the quarter. Strs Ohios holdings in STAAR []

Equities analysts expect STAAR Surgical (NASDAQ:STAA) to report sales of $59.30 million for the current quarter, Zacks reports. Three analysts have made estimates for STAAR Surgicals earnings, with estimates ranging from $59.10 million to $59.40 million. STAAR Surgical posted sales of $46.00 million during the same quarter last year, which suggests a positive year-over-year growth []

STAAR Surgical (NASDAQ:STAA) CTO Keith Holliday sold 6,000 shares of the firms stock in a transaction on Tuesday, December 14th. The shares were sold at an average price of $89.57, for a total transaction of $537,420.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Shares of []